×
About 360 results

ALLMedicine™ Amyopathic Dermatomyositis Center

Research & Reviews  123 results

THE EFFECT OF THERAPEUTIC PLASMA EXCHANGE ON ITRACONAZOLE PHARMACOKINETICS: A CASE STUDY.
https://doi.org/10.1097/FTD.0000000000001057
Therapeutic Drug Monitoring; Seah V, Sreeharan T et. al.

Feb 3rd, 2023 - The authors present the case of a 34-year-old male patient who underwent therapeutic plasma exchange (TPE) for amyopathic dermatomyositis. Immunosuppression resulted in Aspergillus lentulus pulmonary infection, requiring treatment with SUBA-itraco...

WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated wi...
https://doi.org/10.1093/rheumatology/kead006
Rheumatology (Oxford, England); Guo L, Zhang X et. al.

Jan 14th, 2023 - Anti-melanoma differentiation-associated gene 5 antibody positive dermatomyositis (MDA5+DM), is susceptible to development of rapidly progressive interstitial lung disease (RPILD), which has been predominantly reported in East Asia. A Japanese gen...

Elevation of cell-free DNA in patients with clinically amyopathic dermatomyositis.
https://doi.org/10.1111/1346-8138.16714
The Journal of Dermatology; Ishino T, Myangat TM et. al.

Jan 12th, 2023 - Elevation of cell-free DNA in patients with clinically amyopathic dermatomyositis.|2023|Ishino T,Myangat TM,Sawamura S,Kajihara I,Shimada S,|

Clinical and HRCT features of amyopathic dermatomyositis associated with interstitial l...
https://doi.org/10.1016/j.amjms.2022.12.001
The American Journal of the Medical Sciences; Wu T, Zhou H et. al.

Dec 16th, 2022 - This study retrospectively analyzed the laboratory data and chest images of patients with amyopathic dermatomyositis associated with interstitial lung disease (ADM-ILD) and patients with other connective tissue disease-related ILDs (CTD-ILDs) to f...

Progressive interstitial lung disease in hypomyopathic dermatomyositis in the COVID-19 ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877575
International Journal of Rheumatic Diseases; Wang S, Lyu Y et. al.

Dec 12th, 2022 - Clinically amyopathic dermatomyositis (CADM) is characterized by typical skin lesions with no (amyopathic) or subclinical (hypomyopathic) evidence of muscle involvement. Patients with CADM may also develop rapidly progressive interstitial lung dis...

see more →

Clinicaltrials.gov  5 results

Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis
https://clinicaltrials.gov/ct2/show/NCT02245841

Sep 16th, 2021 - Adult and juvenile dermatomyositis (DM) are systemic immune-mediated inflammatory diseases most commonly affecting the skin and musculoskeletal system. Amyopathic dermatomyositis is a subtype of dermatomyositis that affects only the skin and lacks...

The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients
https://clinicaltrials.gov/ct2/show/NCT04966884

Jul 19th, 2021 - Dermatomyositis (DM) is an idiopathic inflammatory myopathy characterized by chronic inflammation in the skin and muscle. Anti-melanoma differentiation-associated gene5 (Anti-MDA5) antibody positive DM is a subtype of DM that is more frequent in E...

Correlation Between the Change of Peripheral Lymphocyte Subsets and Clinically Amyopathic Dermatomyositis Combined With Rapidly Progressive Interstitial Lung Disease
https://clinicaltrials.gov/ct2/show/NCT04613219

Nov 3rd, 2020 - Acute respiratory distress syndrome (ARDS) occurs in Clinically Amyopathic Dermatomyisitis(CADM) combined with Rapidly Progressive Interstitial Lung Disease(RPILD) within 1-3 months, which leads to death of patients and is difficult to treat. Even...

Basiliximab Treating Interstitial Pneumonia of CADM
https://clinicaltrials.gov/ct2/show/NCT03192657

Jun 20th, 2017 - This is a 52-week, randomized, open and routine treatment controlled study. This study will assess the safety and efficacy of basiliximab as an add-on treatment for interstitial pneumonia in clinical amyopathic dermatomyositis (CADM) patients. 100...

Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
https://clinicaltrials.gov/ct2/show/NCT02821689

Jul 1st, 2016 - Interstitial lung disease (ILD) is a common complication of dermatomyositis (DM) with prevalence up to 65%, and is considered to be one of the determining factors of prognosis. Clinical amyopathic dermatomyositis (CADM), which is a special phenoty...

see more →

News  16 results

First Recommendations for Cancer Screening in Myositis Issued
https://www.medscape.com/viewarticle/983972

Nov 12th, 2022 - PHILADELPHIA – The first consensus screening guidelines for patients with idiopathic inflammatory myopathy (IIM) provide recommendations on risk stratification for individuals, basic and enhanced screening protocols, and screening frequency. Alexa...

Validity of commercial serologic tests for dermatomyositis still questionable
https://www.mdedge.com/dermatology/article/249093/autoimmune-diseases/validity-commercial-serologic-tests-dermatomyositis
Doug Brunk

Nov 24th, 2021 - Clinical assessment for pulmonary disease and malignancy in patients with dermatomyositis should not be replaced with serologic tests at this time, according to Jeffrey P. Callen, MD.

Papules and Telangiectases on the Distal Fingers of a Child
https://www.mdedge.com/dermatology/article/198446/pediatrics/papules-and-telangiectases-distal-fingers-child?channel=113
Briana Brown, DO, Jacqueline Jones, DO et. al.

Apr 8th, 2019 - The Diagnosis: Juvenile Dermatomyositis Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory myopathy of childhood that is autoimmune in nature with an annual incidence ranging from 2. 5 to 4.

Papules and Telangiectases on the Distal Fingers of a Child
https://www.mdedge.com/dermatology/article/198446/pediatrics/papules-and-telangiectases-distal-fingers-child
Briana Brown, DO, Jacqueline Jones, DO et. al.

Apr 8th, 2019 - The Diagnosis: Juvenile Dermatomyositis Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory myopathy of childhood that is autoimmune in nature with an annual incidence ranging from 2. 5 to 4.

Timely dermatomyositis diagnosis, treatment remain elusive
https://www.mdedge.com/dermatology/article/167148/lupus-connective-tissue-diseases/timely-dermatomyositis-diagnosis/page/0/1

Jun 3rd, 2018 - “We saw that there was a much higher rate of misdiagnosis in patients who didn’t have any muscle disease. We have to raise awareness that amyopathic dermatomyositis is a very prevalent condition,” Dr.

see more →